Vicente Ferrer HIV Cohort Study
NCT02454569 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30000
Last updated 2023-03-29
Summary
The VFHCS is a long-term prospective cohort study of HIV infected patients from a resource-poor rural setting in India. The aim of the study is to use data collected from routine clinical care in order to describe the epidemiology of HIV and its related conditions in the investigators area, and to study the effectiveness of health interventions in a "real-world" setting (implementation and operational research).
Conditions
- HIV
- Tuberculosis
- Cryptococcosis
- Opportunistic Infections
- Noncommunicable Diseases
Sponsors & Collaborators
-
Rural Development Trust Hospital
lead OTHER
Principal Investigators
-
Gerardo Alvarez-Uria · Rural Development Trust
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2039-09-30
- Completion
- 2040-01-31
Countries
- India
More Related Trials
-
Effect Of A CCR5 Coreceptor Antagonist On The Latency And Reservoir Of HIV-1
NCT00795444 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection
NCT02588820 ·Status: UNKNOWN ·Phase: PHASE3
-
Structured Treatment Interruption for HIV Patients With Virologic Failure
NCT00188851 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Innovative Combinatorial stratégies of Anti-latency and Anti-immune Activation Drugs Targeting HIV Reservoir
NCT04741100 ·Status: WITHDRAWN
-
Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years
NCT03405935 ·Status: COMPLETED ·Phase: PHASE3
-
The Neurocognitive Sub-study of Encore1
NCT01516060 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Effectiveness of Passive Immunotherapy in HIV-Infected Patients Who Are in Virologic Failure
NCT00353327 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program
NCT04650269 ·Status: COMPLETED ·Phase: PHASE4
-
Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)
NCT05312918 ·Status: UNKNOWN
-
Same-Day HIV Testing and Treatment Initiation to Improve Retention in Care
NCT01900080 ·Status: UNKNOWN ·Phase: NA
-
Optimised Electronic Patient Records to Improve Clinical Monitoring of HIV-positive Patients in Rural South Africa
NCT05071573 ·Status: UNKNOWN ·Phase: NA
-
Primary Resistance in HIV Patients in Colombia
NCT03957369 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care
NCT03227861 ·Status: COMPLETED ·Phase: PHASE3
-
Resistance Testing to Improve Management of Virologic Failure in Sub-Saharan Africa
NCT02787499 ·Status: COMPLETED ·Phase: NA
-
Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons
NCT03803605 ·Status: COMPLETED ·Phase: PHASE1
-
RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice
NCT01154556 ·Status: COMPLETED
-
Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants
NCT02269917 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTI Mutation K103N
NCT05349838 ·Status: COMPLETED ·Phase: PHASE3
-
Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis
NCT05492565 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration
NCT00944541 ·Status: COMPLETED ·Phase: PHASE2
-
Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV
NCT05215704 ·Status: RECRUITING
-
Comparing Immune Activation and Latent HIV Reservoir Size Between People Living With HIV on Tenofovir-containing Versus NRTI-free ART
NCT05584397 ·Status: ENROLLING_BY_INVITATION
-
Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants
NCT03631732 ·Status: COMPLETED ·Phase: PHASE3
-
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
NCT00855413 ·Status: TERMINATED ·Phase: PHASE4
-
Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults
NCT02218320 ·Status: COMPLETED